Sang-Hyun Park

Sang-Hyun Park

Auto-generated profile, based on publicly available information

Sang-Hyun Park

From the J. Vernon Luck, Sr., MD Orthopaedic Research Center, Luskin Orthopaedic Institute for Children in Alliance with UCLA (Dr. Park, Ms. Ball, Ms. Rupert, Dr. Sangiorgio, and Dr. Ebramzadeh); the Department of Orthopaedic Surgery (Dr. Park, Dr. Sangiorgio, and Dr. Ebramzadeh); the Department of Life Sciences (Ms. Ball); and the Department of Bioengineering, University of California, Los Angeles, CA (Ms. Rupert and Dr. Sangiorgio)

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2022 in European Spine Journal
Verified
Journal Article
Open access
PDF file
JWJenna M. Wahbeh
Jenna M. Wahbeh
SPSang-Hyun Park
Sang-Hyun Park
PCPatricia Campbell
Patricia Campbell
EEEddie Ebramzadeh
Eddie Ebramzadeh
SSSophia Sangiorgio
Sophia Sangiorgio
Background: Periprosthetic bone loss is a common observation following arthroplasty. Recognizing and understanding the nature of bone loss is vital as it determines the subsequent performance of the device and the overall outcome. Despite its significance, the term “bone loss” is often misused to describe inflammatory osteolysis, a complication with vastly different clinical outcomes and treatment plans. Therefore, the goal of this review was to report major findings related to vertebral radiographic bone changes around cervical disc replacements, mitigate discrepancies in clinical reports by introducing uniform terminology to the field, and establish a precedence that can be used to identify the important nuances between these distinct complications. Methods: A systematic review of the literature was conducted following PRISMA guidelines, using the keywords “cervical,” “disc replacement,” “osteolysis,” “bone loss,” “radiograph,” and “complications.” A total of 23 articles met the inclusion criteria with the majority being retrospective or case reports. Results: Fourteen studies reported periprosthetic osteolysis in a total of 46 patients with onset ranging from 15–96 months after the index procedure. Reported causes included: metal hypersensitivity, infection, mechanical failure, and wear debris. Osteolysis was generally progressive and led to reoperation. Nine articles reported non-inflammatory bone loss in 527 patients (52.5%), typically within 3–6 months following implantation. The reported causes included: micromotion, stress shielding, and interrupted blood supply. With one exception, bone loss was reported to be non-progressive and had no effect on clinical outcome measures. Conclusions: Non-progressive, early onset bone loss is a common finding after CDA and typically does not affect the reported short-term pain scores or lead to early revision. By contrast, osteolysis was less common, presenting more than a year post-operative and often accompanied by additional complications, leading to revision surgery. A greater understanding of the clinical significance is limited by the lack of long-term studies, inconsistent terminology, and infrequent use of histology and explant analyses. Uniform reporting and adoption of consistent terminology can mitigate some of these limitations. Executing these actionable items is critical to assess device performance and the risk of revision. Level of Evidence IV: Diagnostic: individual cross-sectional studies with consistently applied reference standard and blinding.

1 November 2021 in Tissue Engineering Part A
Verified
Journal Article
Closed access
HIHansel Ihn
Hansel Ihn
HKHyunwoo Kang
Hyunwoo Kang
BIBrenda Iglesias
Brenda Iglesias
OSOsamu Sugiyama
Osamu Sugiyama
ATAmy Tang
Amy Tang
JLJay R Lieberman
Jay R Lieberman
Introduction: Regional gene therapy using a lentiviral vector containing the BMP-2 cDNA has been shown to heal critical sized bone defects in rodent models. An appropriate “cellular dose” needs to be defined for eventual translation into human trials. The purpose of this study was to evaluate bone defect healing potential and quality using three different doses of transduced human bone marrow cells (HBMCs). Methods: HBMCs were transduced with a lentiviral vector containing either BMP-2 or green fluorescent protein (GFP). All cells were loaded onto compression resistant matrices and implanted in the bone defect of athymic rats. Treatment groups included femoral defects that were treated with a low dose (1 x 10^6 cells), standard dose (5 x 10^6 cells), and high dose (1.5 x 10^7 cells) HBMCs transduced with lentiviral vector containing BMP-2 cDNA. The 3 control groups were bone defects treated with HBMCs that were either non-transduced or transduced with vector containing GFP. All animals were sacrificed at 12 weeks. The bone formed in each defect was evaluated with plain radiographs, microCT, histomorphometric analysis, and biomechanical testing. Results: Bone defects treated with higher doses of BMP-2 producing cells were more likely to have healed (6/14 of the low dose group; 12/14 of the standard dose group; 14/14 of the high dose group; χ2(2)=15.501, p < 0.001). None of the bone defects in the control groups had healed. Bone defects treated with high dose and standard dose of BMP-2 producing cells consistently outperformed those treated with a low dose in terms of bone formation, as assessed by microCT and histomorphometry, and biomechanical parameters. However, statistical significance was only seen between defects treated with high dose and low dose. Larger doses of BMP-2 producing cells were associated with a higher likelihood of forming heterotopic ossification. Conclusion: Femurs treated with a standard and high dose BMP-2 producing cells demonstrated similar healing and biomechanical properties. Increased doses of BMP-2 delivered via higher cell doses have the potential to heal large bone defects. Adapting regional gene therapy for use in humans will require a balance between promoting bone repair and limiting heterotopic ossification.

1 February 2017 in Bone & Joint Research
Verified
Journal Article
Open access
PDF file
RRR. A. Rajfer
R. A. Rajfer
AKA. Kilic
A. Kilic
ANA. S. Neviaser
A. S. Neviaser
LSL. M. Schulte
L. M. Schulte
SHS. M. Hlaing
S. M. Hlaing
SPS-H. Park
S-H. Park
Objectives We investigated the effects on fracture healing of two up-regulators of inducible nitric oxide synthase (iNOS) in a rat model of an open femoral osteotomy: tadalafil, a phosphodiesterase inhibitor, and the recently reported nutraceutical, COMB-4 (consisting of L-citrulline, Paullinia cupana, ginger and muira puama), given orally for either 14 or 42 days. Materials and Methods Unilateral femoral osteotomies were created in 58 male rats and fixed with an intramedullary compression nail. Rats were treated daily either with vehicle, tadalafil or COMB-4. Biomechanical testing of the healed fracture was performed on day 42. The volume, mineral content and bone density of the callus were measured by quantitative CT on days 14 and 42. Expression of iNOS was measured by immunohistochemistry. Results When compared with the control group, the COMB-4 group exhibited 46% higher maximum strength (t-test, p = 0.029) and 92% higher stiffness (t-test, p = 0.023), but no significant changes were observed in the tadalafil group. At days 14 and 42, there was no significant difference between the three groups with respect to callus volume, mineral content and bone density. Expression of iNOS at day 14 was significantly higher in the COMB-4 group which, as expected, had returned to baseline levels at day 42. Conclusion This study demonstrates an enhancement in fracture healing by an oral natural product known to augment iNOS expression. Cite this article: R. A. Rajfer, A. Kilic, A. S. Neviaser, L. M. Schulte, S. M. Hlaing, J. Landeros, M. G. Ferrini, E. Ebramzadeh, S-H. Park. Enhancement of fracture healing in the rat, modulated by compounds that stimulate inducible nitric oxide synthase: Acceleration of fracture healing via inducible nitric oxide synthase. Bone Joint Res 2017:6:–97. DOI: 10.1302/2046-3758.62.BJR-2016-0164.R2.

25 July 2023 in OTA International
Verified
Journal Article
Open access
JWJenna M. Wahbeh
Jenna M. Wahbeh
BKBenjamin V. Kelley
Benjamin V. Kelley
CSCyrus Bs Shokoohi
Cyrus Bs Shokoohi
SPSang-Hyun Park
Sang-Hyun Park
SDSai K. Devana
Sai K. Devana
DJDevon M. Jeffcoat
Devon M. Jeffcoat
Objectives: Implant prominence after ulnar fracture fixation may be mitigated by the use of lower profile plates. The biomechanical strength and stability of 2.7-mm and 3.5-mm locking compression plates for fixation were compared. Methods: Two fracture conditions, transverse (N = 10) and oblique (N = 10), were evaluated in an in vitro study. Half of the specimens for each condition were fixed with 2.7-mm plates and the other half with 3.5-mm plates, all fixed with conventional dynamic compression mechanisms. Specimens were loaded under ±2 Nm of cyclic axial torsion, then under 10 Nm of cyclic cantilever bending, and bending to failure. Interfragmentary motion and strain were analyzed to determine construct stability as a function of fracture pattern and plate size. Results: Interfragmentary motion was significantly larger in all constructs fixed with 2.7-mm plates, compared with 3.5-mm plates (P < 0.01). The 2.7-mm constructs with transverse fractures had the greatest motion, ranging between 5° and 10° under axial rotation and 5.0–6.0 mm under bending. Motions were the lowest for 3.5-mm constructs with oblique fractures, ranging between 3.2 and 4.2 mm under bending and 2°–3.5° for axial rotation. For oblique fractures, the bending moment at ultimate failure was 31.4 ± 3.6 Nm for the 2.7-mm constructs and 10.0 ± 1.9 Nm for 3.5-mm constructs (P < 0.01). Similarly, for transverse fractures, the bending moment was 17.9 ± 4.0 Nm for the 2.7-mm constructs and 9.7 ± 1.3 Nm for the 3.5-mm constructs (P < 0.01). Conclusions: Although 3.5-mm plates were more effective at reducing fracture motion, they were consistently associated with refracture at the distal-most screw hole under load to failure. By contrast, 2.7-mm plates plastically deformed despite excessive loads, potentially avoiding a subsequent fracture. Level of Evidence: Level V.

21 March 2021 in Journal of Orthopaedic Research
Verified
Journal Article
Open access
PDF file
PCPatricia Campbell
Patricia Campbell
SPSang‐Hyun Park
Sang‐Hyun Park
EEEddie Ebramzadeh
Eddie Ebramzadeh
Numerous studies have examined the histology of metal‐on‐metal hip tissues for evidence of a dose response to metal wear but have often reported inconclusive or contradictory findings. The aim of the present study was to address these discrepancies using multiple histological scoring methods to characterize the tissue features of one large group of revised metal‐on‐metal total hips. Periprosthetic tissues from 165 metal‐on‐metal hip revisions were examined for features of aseptic lymphocytic vasculitis associated lesions (ALVAL) as rated using two scoring systems as well as rankings for macrophage and lymphocyte numbers, intracellular wear debris and necrosis. Correlations between histological features and clinical variables including gender and time to revision and implant variables including articular surface wear volume or visual taper corrosion scores were examined. Both ALVAL scores reflected the macrophage dominated histology with average scores of 5.9/10 and 1.5/3. There was a statistically significant correlation between the original ALVAL score and wear rate per year (correlation coefficient = 0.17, p = .05) and a moderate correlation between the number of macrophages and wear particles and wear volume. There was no statistically significant correlation between wear and any other feature including lymphocytic inflammation or necrosis. Strong correlations between combined cup and ball wear volume and histological characteristics were not observed, although the number of macrophages was more closely correlated with wear than lymphocytes or necrosis.

1 April 2021 in Foot and Ankle Surgery
Verified
Journal Article
Closed access
NHNathan C. Ho
Nathan C. Ho
SPSang-Hyun Park
Sang-Hyun Park
PCPatricia Campbell
Patricia Campbell
DCDouglas W Van Citters
Douglas W Van Citters
EEEddie Ebramzadeh
Eddie Ebramzadeh
SSSophia Sangiorgio
Sophia Sangiorgio